Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
FDA Approves Abrysvo (respiratory syncytial virus vaccine) for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
NEW YORK--(BUSINESS WIRE) May 31, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo&trade...
Stress-Management Interventions May Aid Health Care Workers
WEDNESDAY, May 31, 2023 -- Stress-management interventions may help individual health care workers over the short term, according to research published online...
APA: Ketamine Noninferior to ECT for Treatment-Resistant Depression
WEDNESDAY, May 31, 2023 -- For patients with treatment-resistant major depression without psychosis, ketamine is noninferior to electroconvulsive therapy...
Recent Increase Seen for Pediatric Firearm-Related Injuries
WEDNESDAY, May 31, 2023 -- From 2016 to 2020, there was an increase in pediatric firearm-related injuries, with community violence and negligent discharges...
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
WEDNESDAY, May 31, 2023 -- Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they are getting the medication, the...
Atopic Dermatitis Tied to Higher Venous Thromboembolism Risk
WEDNESDAY, May 31, 2023 -- Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study...
Sickle Cell Gene Therapy Can Cure, But Costs Almost $3 Million. Who Will Pay?
WEDNESDAY, May 31, 2023 -- An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether...
Prostatitis: What It Is, Symptoms, Causes & Treatment
WEDNESDAY, May 31, 2023 -- When most men think about their prostate, it's to worry about whether they have prostate cancer or not. But another condition is far...
Baby Boys 'Talk' More During First Year Compared to Girls
WEDNESDAY, May 31, 2023 -- Girls have long been thought to have a language advantage over boys as infants. But new research finds that boys make more...
Mind-Body Effects of Qigong Might Help Ease Cancer-Related Fatigue
WEDNESDAY, May 31, 2023 -- When the late Brown University researcher Catherine Kerr had cancer, she benefited from an ancient Chinese practice known as qigong...
Men’s Mental Health: Symptoms, Treatments & Where to Find Help
WEDNESDAY, May 31, 2023 -- When it comes to mental health, men don't always seek help when they need it. But maybe they should. June is Men's Mental Health...
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
Application based on results from the registrational TRIDENT-1 trial, in which repotrectinib demonstrated high response rates and durable responses in...
FDA Approves Posluma (flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer
MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE) May 30, 2023 --Blue Earth Diagnostics, a Bracco company and recognized leader in the development...
FDA Approves Inpefa (sotagliflozin) for the Treatment of Heart Failure
THE WOODLANDS, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration...
Takeda and Hutchmed Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
OSAKA, Japan, CAMBRIDGE, Massachusetts, HONG KONG, SHANGHAI &, FLORHAM PARK, New Jersey, Friday May 26, 2023 – Takeda (TSE:4502/NYSE:TAK) and...
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
SAN CARLOS, Calif., May 26, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing...
FDA Approves Paxlovid (nirmatrelvir tablets and ritonavir tablets) for Adult Patients at High Risk of Progression to Severe COVID-19
NEW YORK--(BUSINESS WIRE) May 25, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved Paxlovid&trade...
FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira
JERSEY CITY, N.J.--(BUSINESS WIRE) May 24, 2023 --Celltrion USA today announced that the U.S. Food and Drug Administration (FDA) has approved Yuflyma®...
Phathom Pharmaceuticals Resubmits Vonoprazan Erosive GERD New Drug Application to FDA
FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and...
Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma
Fort Lee, N.J., May 17, 2023 - Elevar Therapeutics, Inc., a wholly owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated...
NIH Scientists Find Treatment for Rare Genetic Skin Disorder
May 31, 2023 -- Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe...
Research and Pipeline Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
Study demonstrates statistically significant and clinically relevant reduction in annualized bleeding rate compared to prophylaxis and on-demand intravenous...
First Subject Dosed in a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Vaccine Developed for the Prevention of Shingles
MORRISVILLE, N.C., May 30, 2023. Immorna, a rapidly expanding biotechnology company focusing on the development of multi-platform RNA-based therapeutics and...
AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer
MELBOURNE, Australia, May 29, 2023. Amplia Therapeutics Limited ("Amplia" or the "Company") is pleased to announce new data showing the efficacy of its...
CHOP Researchers Show that IgA Fine Tunes the Body's Interactions with Microbes
PHILADELPHIA, May 26, 2023. IgA deficiency is the most common primary immune deficiency worldwide, but its presentation has puzzled physcians and researchers...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.